Sodium Benzoate
Sponsors
Klinikum der Technischen Universitaet Muenchen (TUM Klinikum), National Center for Research Resources (NCRR), Niuvanniemi Hospital, Baylor College of Medicine, Pakistan Institute of Living and Learning
Conditions
Amino Acid Metabolism, Inborn ErrorsAttenuated or Transient PsychosisChronic Liver DiseaseCorticobasal Syndrome (CBS)Schizoaffective DisorderSchizophreniaSchizophreniform DisordersUrea Cycle Disorders, Inborn
Phase 2
Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders
CompletedNCT00004767
Start: 1985-01-31Target: 20Updated: 2005-06-24
Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial.
WithdrawnNCT02026947
Start: 2014-02-28End: 2016-12-31Updated: 2014-04-10
Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.
CompletedNCT03510741
Start: 2019-01-01End: 2021-03-30Updated: 2022-04-27
Double-blind, randomised, prospective, placebo controlled parallel group phase II study to investigate the effect of glycerol phenylbutyrate (GPB) on neurofilament light chain (NfL) levels in patients with corticobasal syndrome (CBS)
Active, not recruitingCTIS2024-516897-31-00
Start: 2023-12-01Target: 32Updated: 2025-09-18
Unknown Phase
Comparative Efficacy of Phenylbutyrate (PBA) vs. Benzoate in Urea Cycle Disorders
CompletedNCT02111200
Start: 2014-09-30End: 2015-10-31Updated: 2018-01-09
Efficacy and Safety of Sodium Benzoate in the Management of Hyperammonemia in Infants, Children and Adolescent With Chronic Liver Disease.
CompletedNCT04022941
Start: 2017-04-01End: 2018-12-31Updated: 2019-07-17